BR112016029713A8 - uso de uma carboximetilcelulose reticulada e uso de um agente gelificante - Google Patents

uso de uma carboximetilcelulose reticulada e uso de um agente gelificante

Info

Publication number
BR112016029713A8
BR112016029713A8 BR112016029713A BR112016029713A BR112016029713A8 BR 112016029713 A8 BR112016029713 A8 BR 112016029713A8 BR 112016029713 A BR112016029713 A BR 112016029713A BR 112016029713 A BR112016029713 A BR 112016029713A BR 112016029713 A8 BR112016029713 A8 BR 112016029713A8
Authority
BR
Brazil
Prior art keywords
cross
linked carboxymethylcellulose
gelling agent
subject
steps
Prior art date
Application number
BR112016029713A
Other languages
English (en)
Other versions
BR112016029713A2 (pt
Inventor
Sannino Alessandro
S Ron Eyal
Heshmati Hassan
Zohar Yishai
Original Assignee
Gelesis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelesis Llc filed Critical Gelesis Llc
Publication of BR112016029713A2 publication Critical patent/BR112016029713A2/pt
Publication of BR112016029713A8 publication Critical patent/BR112016029713A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

uso de uma carboximetilcelulose reticulada e uso de um agente gelificante. a presente invenção refere-se aos métodos de gestão do peso e o tratamento da obesidade ou excesso de peso e o tratamento ou prevenção da diabetes em um indivíduo em necessidade dos mesmos. em uma modalidade, o método compreende as etapas de (a) administrar por via oral ao indivíduo de cerca de 0,7 g a cerca de 4 g de carboximetilcelulose reticulada; e (b) administrar por via oral ao indivíduo pelo menos cerca de 100 ml de água por grama de carboximetilcelulose reticulada. as etapas (a) e (b) são conduzidas antes de ou com, pelo menos, uma refeição por dia.
BR112016029713A 2014-06-20 2015-06-19 uso de uma carboximetilcelulose reticulada e uso de um agente gelificante BR112016029713A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014926P 2014-06-20 2014-06-20
PCT/US2015/036654 WO2015196054A1 (en) 2014-06-20 2015-06-19 Methods for treating overweight or obesity

Publications (2)

Publication Number Publication Date
BR112016029713A2 BR112016029713A2 (pt) 2017-08-22
BR112016029713A8 true BR112016029713A8 (pt) 2021-07-20

Family

ID=54868671

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016029713A BR112016029713A8 (pt) 2014-06-20 2015-06-19 uso de uma carboximetilcelulose reticulada e uso de um agente gelificante

Country Status (11)

Country Link
US (3) US9855294B2 (pt)
EP (1) EP3157536A4 (pt)
JP (1) JP6726109B2 (pt)
KR (2) KR20230085212A (pt)
CN (2) CN106470689A (pt)
AU (1) AU2015276889B2 (pt)
BR (1) BR112016029713A8 (pt)
CA (1) CA2950482C (pt)
MX (1) MX2016016800A (pt)
RU (1) RU2696494C2 (pt)
WO (1) WO2015196054A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001629A (es) * 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
KR101992449B1 (ko) * 2011-06-07 2019-06-24 젤레시스 엘엘씨 하이드로겔 생성 방법
JP6726109B2 (ja) 2014-06-20 2020-07-22 ジェレシス，エルエルシー 過体重または肥満を治療するための組成物
MX2017009805A (es) 2015-01-29 2018-05-07 Gelesis Llc Método para la producción de hidrogeles que juntan alto módulo elástico y absorbancia.
MX2017015247A (es) 2015-06-01 2018-08-28 Xeno Biosciences Inc Metodos y composiciones para modular la microbiota intestinal y para manejar el peso.
WO2017189422A1 (en) * 2016-04-25 2017-11-02 Gelesis, Llc. Method for treating constipation
EP3468670B1 (en) * 2016-06-10 2023-12-13 University of Copenhagen Predetermined diet for use in inducing weight loss and preventing weight gain
WO2017213961A1 (en) * 2016-06-10 2017-12-14 Gelesis Llc Methods of inducing weight loss, treating obesity and preventing weight gain
CN110520111B (zh) 2016-11-30 2023-12-19 塞诺生物科学股份有限公司 用以管理体重和调节肠道微生物群的药物制剂和方法
BR112019020724A2 (pt) 2017-04-05 2020-05-12 Gelesis, Llc Materiais superabsorventes melhorados e métodos de produção dos mesmos
KR20200003827A (ko) * 2017-04-14 2020-01-10 젤레시스 엘엘씨 장 투과성-관련 장애를 치료 또는 예방하기 위한 조성물 및 방법
US11918602B2 (en) 2018-08-10 2024-03-05 Simeon Investment, Inc. Methods for reducing cholesterol with superabsorbent materials
US11925660B2 (en) 2018-08-10 2024-03-12 Simeon Investment, Inc. Treatment for obesity with superabsorbent materials
US20220257637A1 (en) * 2019-10-01 2022-08-18 Brillian Pharma Inc. Methods for treating or preventing obesity and body weight management
RU2749484C1 (ru) * 2020-06-18 2021-06-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Способ оценки массы тела человека
CN116003830A (zh) * 2021-03-23 2023-04-25 叶绿体(新加坡)有限公司 超吸收性水凝胶及其制备方法和应用
CN114009797A (zh) * 2021-11-17 2022-02-08 上海市第十人民医院 一种减肥组合物及其制备方法和应用
CN114381014B (zh) * 2021-12-16 2023-02-17 佑道(天津)健康咨询有限公司 一种可生物降解的水凝胶及其应用
CN114702734A (zh) * 2022-04-08 2022-07-05 重庆师范大学 一种纤维素醚类凝胶及其制备方法和应用
CN116807980A (zh) * 2023-07-10 2023-09-29 橡果美健实业投资股份有限公司 用于肥胖干预的胃内占容水凝胶颗粒的制备方法及应用

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE212969C (pt)
US3526048A (en) 1967-06-07 1970-09-01 Us Agriculture Cellulose fibers cross-linked and esterified with polycarboxylic acids
DD212969A1 (de) 1982-12-30 1984-08-29 Adw Inst Polymerenchemie Verfahren zur modifizierung von carboxymethylcellulose
JPS62141001A (ja) 1985-12-13 1987-06-24 Dai Ichi Kogyo Seiyaku Co Ltd 水不溶性のカルボキシアルキルセルロ−ス・アルカリ金属塩の製造方法
JPH01187048A (ja) 1988-01-18 1989-07-26 Dai Ichi Kogyo Seiyaku Co Ltd 糠漬け用組成物
US5137537A (en) 1989-11-07 1992-08-11 The Procter & Gamble Cellulose Company Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers
JPH05507948A (ja) 1990-04-18 1993-11-11 ユニバーシティ オブ ユタ リサーチ ファウンデーション アゾ結合を含み、ｐＨ依存性膨潤を示す、架橋したヒドロゲルに基づいた、結腸を標的にした経口薬の投薬形態
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
US5247072A (en) 1991-10-25 1993-09-21 Kimberly-Clark Corporation Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof
US5550189A (en) 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
DK0661045T3 (da) 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
JP3274550B2 (ja) 1993-08-03 2002-04-15 株式会社日本触媒 吸水材の製法
EP0750693B1 (en) 1994-03-18 1998-11-25 The Procter & Gamble Company Preparing individualized polycarboxylic acid crosslinked cellulosic fibers
AU3274895A (en) 1994-07-18 1996-02-16 Gel Sciences, Inc. Novel polymer gel networks and methods of use
BR9509869A (pt) 1994-12-09 1997-11-25 Procter & Gamble Composto absorvente e processo para produzir esse composto absorvente
US20010006677A1 (en) 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19654745C5 (de) 1996-12-30 2004-01-22 Lechner, M.D., Prof. Dr. Biologisch abbaubares Absorptionsmittel, dessen Herstellung und Verwendung
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
AU3561697A (en) 1997-06-24 1999-01-04 Sca Molnlycke Ab Absorbent polymer material based on renewable starting materials
CO5070628A1 (es) 1997-11-25 2001-08-28 Kimberly Clark Co Espuma absorbente que comprende un polimero, el producto absorbente que la comprende y el proceso para su preparacion
WO2000032064A1 (en) 1998-11-30 2000-06-08 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
TNSN99243A1 (fr) 1998-12-16 2001-12-31 Sca Hygiene Prod Zeist Bv Polysaccharides superabsorbants acides
US6471824B1 (en) 1998-12-29 2002-10-29 Weyerhaeuser Company Carboxylated cellulosic fibers
US6867346B1 (en) 1999-09-21 2005-03-15 Weyerhaeuser Company Absorbent composite having fibrous bands
EP1134232A1 (en) 2000-03-16 2001-09-19 SCA Hygiene Products AB Polysaccharide-based superabsorbent film
WO2001087365A2 (en) 2000-05-15 2001-11-22 Kimberly-Clark Worldwide, Inc. Polysaccharide absorbent and method
US6472006B1 (en) 2001-04-05 2002-10-29 Kraft Foods Holdings, Inc. Oven-stable edible moisture barrier
DE10125599A1 (de) 2001-05-25 2002-11-28 Stockhausen Chem Fab Gmbh Superabsorber, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2271287T3 (es) 2001-06-28 2007-04-16 Basf Aktiengesellschaft Hidrogeles acidos altamente capaces de hincharse.
JP4132993B2 (ja) 2002-06-03 2008-08-13 住友精化株式会社 吸水性樹脂およびその製造方法
US7648619B2 (en) 2002-06-04 2010-01-19 Industrial Technology Research Hydrogel-driven micropump
AU2003299838A1 (en) 2002-12-19 2004-07-14 Polymorfix, Inc. Ingestible formulations for transient, noninvasive reduction of gastric volume
NL1023257C2 (nl) 2003-04-24 2004-10-27 Tno Vochtwerende bekledingslaag voor voedingsmiddelen.
CA2584188C (en) 2003-10-16 2014-03-18 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US20050143571A1 (en) 2003-12-30 2005-06-30 Weyerhaeuser Company Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color
JP5465832B2 (ja) 2004-06-21 2014-04-09 エボニック デグサ ゲーエムベーハー 吸水性多糖類及びその製造方法
CA2588147A1 (en) 2004-12-08 2006-06-15 Unilever Plc Satiety enhancing food product and a method for manufacturing such
US20060142478A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
ITTO20040918A1 (it) 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
US20060142480A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Method of making carboxyalkyl cellulose polymer network
CA2594155C (en) 2004-12-30 2016-08-30 Commonwealth Scientific And Industrial Research Organisation A process for producing a food or beverage
JP2009502908A (ja) 2005-07-29 2009-01-29 スティッチング グロニンゲン セントル フォー ドラッグ リサーチ ｐＨ制御パルス送達システム、その調製法及び使用法
MX2008012248A (es) 2006-03-28 2009-02-20 Gelesis Inc Uso de materiales polimericos con otras sustancias para rendimiento mejorado.
CA2646050A1 (en) * 2006-03-30 2007-10-11 Gelesis, Inc. Styrene-maleic anhydride copolymers for bioapplications and their preparation
WO2007115165A2 (en) 2006-03-30 2007-10-11 Gelesis, Inc. Styrene-maleic anhydride copolymers for bioapplications and their preparation
GB2445818B8 (en) 2006-09-15 2011-06-22 Japan Atomic Energy Agency Preparation of gels derived from carboxymethyl cellulose alkali metal salt
JP4288618B2 (ja) 2006-09-15 2009-07-01 独立行政法人 日本原子力研究開発機構 カルボキシメチルセルロースゲルの製造方法
US20080147026A1 (en) 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
JP2008195649A (ja) 2007-02-13 2008-08-28 Daicel Chem Ind Ltd 害虫防除用ベイト剤及びその製造方法
US10716828B2 (en) * 2007-05-02 2020-07-21 Dana-Farber Cancer Institute, Inc. Methods of modulating cellular homeostatic pathways and cellular survival
JP2008285611A (ja) 2007-05-18 2008-11-27 Daicel Chem Ind Ltd 架橋ゲルの製造方法及びその架橋ゲル
MX2010001629A (es) 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US8039683B2 (en) 2007-10-15 2011-10-18 Kimberly-Clark Worldwide, Inc. Absorbent composites having improved fluid wicking and web integrity
US9345809B2 (en) 2007-11-28 2016-05-24 Fziomed, Inc. Carboxymethylcellulose polyethylene glycol compositions for medical uses
CN102281771A (zh) * 2008-11-18 2011-12-14 万有限责任公司 用于体重管理和改善血糖控制的方法和组合物
RU2441654C2 (ru) * 2010-02-17 2012-02-10 Лабораториос Баго С.А. Фармацевтическая композиция с активностью против ожирения, включающая премикс чистого орлистата, и способ ее изготовления
KR101992449B1 (ko) * 2011-06-07 2019-06-24 젤레시스 엘엘씨 하이드로겔 생성 방법
JP6726109B2 (ja) 2014-06-20 2020-07-22 ジェレシス，エルエルシー 過体重または肥満を治療するための組成物
MX2017009805A (es) * 2015-01-29 2018-05-07 Gelesis Llc Método para la producción de hidrogeles que juntan alto módulo elástico y absorbancia.
WO2017189422A1 (en) 2016-04-25 2017-11-02 Gelesis, Llc. Method for treating constipation

Also Published As

Publication number Publication date
BR112016029713A2 (pt) 2017-08-22
EP3157536A4 (en) 2018-01-24
US10953038B2 (en) 2021-03-23
AU2015276889A1 (en) 2016-11-24
EP3157536A1 (en) 2017-04-26
CN115381850A (zh) 2022-11-25
MX2016016800A (es) 2017-05-03
KR20230085212A (ko) 2023-06-13
RU2696494C2 (ru) 2019-08-02
JP6726109B2 (ja) 2020-07-22
US20210260099A1 (en) 2021-08-26
KR20170029432A (ko) 2017-03-15
WO2015196054A1 (en) 2015-12-23
US20180153925A1 (en) 2018-06-07
US20150366898A1 (en) 2015-12-24
AU2015276889B2 (en) 2019-04-18
JP2017519751A (ja) 2017-07-20
US11628184B2 (en) 2023-04-18
CA2950482C (en) 2022-12-06
CA2950482A1 (en) 2015-12-23
RU2016148609A (ru) 2018-07-20
RU2016148609A3 (pt) 2019-01-17
US9855294B2 (en) 2018-01-02
CN106470689A (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
BR112016029713A8 (pt) uso de uma carboximetilcelulose reticulada e uso de um agente gelificante
CY1125144T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρηση αυτης
EP4344706A3 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
BR112016008409A2 (pt) Uso de um agente inibidor de masp-2 que inibe a ativação de complemento dependente de masp-2
WO2015106128A3 (en) Rnai agents modified at the 4'-c-position
BR112016013148A2 (pt) "composições de rnai de componente do complemento e métodos de utilização das mesmas
EA201400119A1 (ru) Фармацевтическая композиция, способы лечения и их применение
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
EP4324845A3 (en) Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
PH12019501018A1 (en) Pharmaceutical composition, methods for treating and uses thereof
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
EA201690964A1 (ru) Композиции и способы для уменьшения серьезных неблагоприятных сердечно-сосудистых явлений
BR112016030774A2 (pt) anticorpo ou fragmento de ligação a antígeno do mesmo, uso de um anticorpo, métodos para redução da quantidade de protofibrilas de ?? em um indivíduo, para tratamento e/ou para profilaxia de uma doença, para medição da quantidade de protofibrilas de ?? e/ou de proteína ?? agregada em uma pessoa, e para diagnóstico de uma doença, e, composição farmacêutica
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
BR112018006006A2 (pt) receptores de antígeno, cadeias peptídicas, células recombinantes, métodos para produzir uma célula que expressa um receptor de antígeno e para o tratamento de uma doença, ácidos nucleicos e composição farmacêutica
EA201790475A1 (ru) Способы лечения системной красной волчанки с использованием доменного антитела против cd28
BR112017006416A2 (pt) composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
MX2020012800A (es) Cannabinoides y usos de los mismos.
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
BR112017008805A2 (pt) tratamento de córnea usando laminina
BR112016023450A2 (pt) uso de compostos ctla4 para alcançar remissão livre de fármacos em indivíduos com artrite reumatoide precoce
BR112015024703A2 (pt) formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose
PH12015502100A1 (en) Reducing the risk of autoimmune disease

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/715 (2006.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]